Male-female differences in diabetic retinopathy?

Current Eye Research

Volumn 40, Issue 2, 2015, Pages 234-246

  Ozawa, Glen Y ^a   Bearse, Marcus A ^a   Adams, Anthony J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Diabetes; Diabetic retinopathy; Electroretinogram; Gender; Multifocal ERG; Neuroretinal function; Sex differences

Indexed keywords

DIABETIC RETINOPATHY; HORMONAL THERAPY; HUMAN; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; MENOPAUSE; MENSTRUAL CYCLE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OPHTHALMOSCOPY; ORAL CONTRACEPTION; PARITY; PREGNANCY; PREVALENCE; PRIORITY JOURNAL; REVIEW; SEX DIFFERENCE; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; ELECTRORETINOGRAPHY; FEMALE; MALE; PATHOPHYSIOLOGY; RETINA;

DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; ELECTRORETINOGRAPHY; FEMALE; HUMANS; INCIDENCE; MALE; PREVALENCE; RETINA; SEX FACTORS;

EID: 84921641431     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.3109/02713683.2014.958500     Document Type: Review

References (128)

1. World Health Organization. 10 Facts about Diabetes October 2013. http://www.who.int/features/factfiles/diabetes/en/. [last accessed 4 Sep 2014].
2. Bloomgarden ZT. Type 2 diabetes in the young: The evolving epidemic. Diabetes Care 2004;27:998-1010.
3. International Diabetes Foundation. IDF Diabetes Atlas, 5th Ed. Brussels, Belgium: International Diabetes Federation, 2012. http://www.idf.org/sites/default/files/attachments/5E-IDFAtlasPoster-2012-EN.pdf?utm-medium=email&utm-campaign=IDF%20Diabetes%20Atlas%202012%20Update& utm-content=IDF%20Diabetes%20Atlas%202012%20Update +Preview+CID-720a5262162f1f585ba9fc8ca39fef30utm-source=campaignmonitor&utm-term=English. [last accessed 4 Sep 2014].
4. Del Prato S. Role of glucotoxicity and lipotoxicity in the pathophysiology of Type 2 diabetes mellitus and emerging treatment strategies. Diabet Med 2009;26:1185-1192.
5. Maahs DM, West NA, Lawrence JM, Mayer-Davis EJ. Epidemiology of type 1 diabetes. Endocrinol Metab Clin North Am 2010;39:481-497.
6. Gleicher N, Barad DH. Gender as risk factor for autoimmune diseases. J Autoimmun 2007;28:1-6.
7. Ostman J, Lonnberg G, Arnqvist HJ, Blohme G, Bolinder J, Ekbom Schnell A, et al. Gender differences and temporal variation in the incidence of type 1 diabetes: Results of 8012 cases in the nationwide Diabetes Incidence Study in Sweden 1983-2002. J Intern Med 2008;263:386-394.
8. Ostrauskas R, Zalinkevicius R, Jurgeviciene N, Radzeviciene L, Lasaite L. The incidence of type 1 diabetes mellitus among 15-34 years aged Lithuanian population: 18-year incidence study based on prospective databases. BMC Public Health 2011;11:813.
9. Lammi N, Taskinen O, Moltchanova E, Notkola IL, Eriksson JG, Tuomilehto J, et al. A high incidence of type 1 diabetes and an alarming increase in the incidence of type 2 diabetes among young adults in Finland between 1992 and 1996. Diabetologia 2007;50:1393-1400.
10. Bruno G, Merletti F, Vuolo A, Pisu E, Giorio M, Pagano G. Sex differences in incidence of IDDM in age-group 15-29 yr. Higher risk in males in Province of Turin, Italy. Diabetes Care 1993;16:133-136.
11. Weets I, De Leeuw IH, Du Caju MV, Rooman R, Keymeulen B, Mathieu C, et al. The incidence of type 1 diabetes in the age group 0-39 years has not increased in Antwerp (Belgium) between 1989 and 2000: Evidence for earlier disease manifestation. Diabetes Care 2002;25:840-846.
12. Bell RA, Mayer-Davis EJ, Beyer JW, D'Agostino RB, Lawrence JM, Linder B, et al. Diabetes in non-Hispanic white youth: Prevalence, incidence, and clinical characteristics: The SEARCH for Diabetes in Youth Study. Diabetes Care 2009;32:S102-S111.
13. Mayer-Davis EJ, Beyer J, Bell RA, Dabelea D, D'Agostino R, Imperatore G, et al. Diabetes in African American youth: Prevalence, incidence, and clinical characteristics: The SEARCH for Diabetes in Youth Study. Diabetes Care 2009;32:S112-S122.
14. Lawrence JM, Mayer-Davis EJ, Reynolds K, Beyer J, Pettitt DJ, D'Agostino RB, et al. Diabetes in Hispanic American youth: Prevalence, incidence, demographics, and clinical characteristics: The SEARCH for Diabetes in Youth Study. Diabetes Care 2009;32:S123-S132.
15. Liu LL, Yi JP, Beyer J, Mayer-Davis EJ, Dolan LM, Dabelea DM, et al. Type 1 and Type 2 diabetes in Asian and Pacific Islander U.S. youth: The SEARCH for Diabetes in Youth Study. Diabetes Care 2009;32:S133-S140.
16. Pundziute-Lycka A, Dahlquist G, Nystrom L, Arnqvist H, Bjork E, Blohme G, et al. The incidence of Type I diabetes has not increased but shifted to a younger age at diagnosis in the 0-34 years group in Sweden 1983-1998. Diabetologia 2002;45:783-791.
17. Koton S. Israel IDDM Registry Study Group-IIRSG. Incidence of type 1 diabetes mellitus in the 0-to 17-yr-old Israel population, 1997-2003. Pediatr Diabetes 2007;8: 60-66.
18. Moran A, Jacobs DR, Steinberger J, Hong CP, Prineas R, Luepker R, et al. Insulin resistance during puberty: Results from clamp studies in 357 children. Diabetes 1999;48: 2039-2044.
19. Moran A, Jacobs DR, Steinberger J, Steffen LM, Pankow JS, Hong CP, et al. Changes in insulin resistance and cardiovascular risk during adolescence: Establishment of differential risk in males and females. Circulation 2008;117: 2361-2368.
20. DIAMOND Project Group. Incidence and trends of childhood Type 1 diabetes worldwide 1990-1999. Diabet Med 2006;23:857-866.
21. Karvonen M, Pitkaniemi M, Pitkaniemi J, Kohtamaki K, Tajima N, Tuomilehto J. Sex difference in the incidence of insulin-dependent diabetes mellitus: An analysis of the recent epidemiological data. World Health Organization DIAMOND Project Group. Diabetes Metab Rev 1997;13: 275-291.
22. Karvonen M, Viik-Kajander M, Moltchanova E, Libman I, LaPorte R, Tuomilehto J. Incidence of childhood type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) Project Group. Diabetes Care 2000;23:1516-1526.
23. Fazeli Farsani S, van der Aa MP, van der Vorst MM, Knibbe CA, de Boer A. Global trends in the incidence and prevalence of type 2 diabetes in children and adolescents: A systematic review and evaluation of methodological approaches. Diabetologia 2013;56:1471-1488.
24. Wei JN, Sung FC, Lin CC, Lin RS, Chiang CC, Chuang LM. National surveillance for type 2 diabetes mellitus in Taiwanese children. JAMA 2003;290:1345-1350.
25. Awa WL, Fach E, Krakow D, Welp R, Kunder J, Voll A, et al. Type 2 diabetes from pediatric to geriatric age: Analysis of gender and obesity among 120,183 patients from the German/Austrian DPV database. Eur J Endocrinol 2012;167:245-254.
26. Copeland KC, Zeitler P, Geffner M, Guandalini C, Higgins J, Hirst K, et al. Characteristics of adolescents and youth with recent-onset type 2 diabetes: The TODAY cohort at baseline. J Clin Endocrinol Metab 2011;96:159-167.
27. Liese AD, D'Agostino RB, Hamman RF, Kilgo PD, Lawrence JM, Liu LL, et al. The burden of diabetes mellitus among US youth: Prevalence estimates from the SEARCH for Diabetes in Youth Study. Pediatrics 2006;118: 1510-1518.
28. Hu D, Sun L, Fu P, Xie J, Lu J, Zhou J, et al. Prevalence and risk factors for type 2 diabetes mellitus in the Chinese adult population: The InterASIA Study. Diabetes Res Clin Pract 2009;84:288-295.
29. DECODE Study Group. Age-and sex-specific prevalences of diabetes and impaired glucose regulation in 13 European cohorts. Diabetes Care 2003;26:61-69.
30. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: Prevalence, numerical estimates, and projections. Diabetes Care 1998;21:1414-1431.
31. Schipf S, Werner A, Tamayo T, Holle R, Schunk M, Maier W, et al. Regional differences in the prevalence of known Type 2 diabetes mellitus in 45-74 years old individuals: Results from six population-based studies in Germany (DIAB-CORE Consortium). Diabet Med 2012;29: E88-e95.
32. Pan C, Yang W, Jia W, Weng J, Tian H. Management of Chinese patients with type 2 diabetes, 1998-2006: The Diabcare-China surveys. Curr Med Res Opin 2009;25: 39-45.
33. Inoue M, Inoue K, Akimoto K. Effects of age and sex in the diagnosis of type 2 diabetes using glycated haemoglobin in Japan: The Yuport Medical Checkup Centre study. PLoS One 2012;7:e40375.
34. Lin CC, Li CI, Hsiao CY, Liu CS, Yang SY, Lee CC, et al. Time trend analysis of the prevalence and incidence of diagnosed type 2 diabetes among adults in Taiwan from 2000 to 2007: A population-based study. BMC Public Health 2013;13:318.
35. Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J, et al. Prevalence of diabetes among men and women in China. N Engl J Med 2010;362:1090-1101.
36. Kaiser A, Vollenweider P, Waeber G, Marques-Vidal P. Prevalence, awareness and treatment of type 2 diabetes mellitus in Switzerland: The CoLaus study. Diabet Med 2012;29:190-197.
37. Tian H, Song G, Xie H, Zhang H, Tuomilehto J, Hu G. Prevalence of diabetes and impaired fasting glucose among 769,792 rural Chinese adults. Diabetes Res Clin Pract 2009;84:273-278.
38. Nguyen QM, Xu JH, Chen W, Srinivasan SR, Berenson GS. Correlates of age onset of type 2 diabetes among relatively young black and white adults in a community: The Bogalusa Heart Study. Diabetes Care 2012;35: 1341-1346.
39. Sivaprasad S, Gupta B, Crosby-Nwaobi R, Evans J. Prevalence of diabetic retinopathy in various ethnic groups: A worldwide perspective. Surv Ophthalmol 2012; 57:347-370.
40. Yau JW, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski JW, Bek T, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 2012;35: 556-564.
41. Romero P, Baget M, Mendez I, Fernandez J, Salvat M, Martinez I. Diabetic macular edema and its relationship to renal microangiopathy: A sample of Type I diabetes mellitus patients in a 15-year follow-up study. J Diabetes Comp 2007;21:172-180.
42. Bodansky HJ, Cudworth AG, Whitelocke RA, Dobree JH. Diabetic retinopathy and its relation to type of diabetes: Review of a retinal clinic population. Br J Ophthalmol 1982; 66:496-499.
43. Klein R, Knudtson MD, Lee KE, Gangnon R, Klein BE. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XXII the twenty-five-year progression of retinopathy in persons with type 1 diabetes. Ophthalmology 2008;115: 1859-1868.
44. Roy MS, Affouf M. Six-year progression of retinopathy and associated risk factors in African American patients with type 1 diabetes mellitus: The New Jersey. Arch Ophthalmol 2006;124:1297-1306.
45. Chaturvedi N, Sjoelie AK, Porta M, Aldington SJ, Fuller JH, Songini M, et al. Markers of insulin resistance are strong risk factors for retinopathy incidence in type 1 diabetes. Diabetes Care 2001;24:284-289.
46. Hammes HP, Kerner W, Hofer S, Kordonouri O, Raile K, Holl RW, et al. Diabetic retinopathy in type 1 diabetes-A contemporary analysis of 8,784 patients. Diabetologia 2011; 54:1977-1984.
47. Walsh MG, Zgibor J, Borch-Johnsen K, Orchard TJ. A multinational assessment of complications in type 1 diabetes: The DiaMond substudy of complications (DiaComp) Level 1. Diab Vasc Dis Res 2006;3:80-83.
48. Klein R, Knudtson MD, Lee KE, Gangnon R, Klein BE. The Wisconsin Epidemiologic Study of Diabetic Retinopathy XXIII: The twenty-five-year incidence of macular edema in persons with type 1 diabetes. Ophthalmology 2009;116:497-503.
49. Roy MS, Klein R, O'Colmain BJ, Klein BE, Moss SE, Kempen JH. The prevalence of diabetic retinopathy among adult type 1 diabetic persons in the United States. Arch Ophthalmol 2004;122:546-551.
50. Younis N, Broadbent DM, Harding SP, Vora JR. Prevalence of diabetic eye disease in patients entering a systematic primary care-based eye screening programme. Diabet Med 2002;19:1014-1021.
51. Younis N, Broadbent DM, Vora JP, Harding SP, Study LDE. Incidence of sight-threatening retinopathy in patients with type 2 diabetes in the Liverpool Diabetic Eye Study: A cohort study. Lancet 2003;361:195-200.
52. Salti HI, Nasrallah MP, Taleb NM, Merheb M, Haddad S, El-Annan J, et al. Prevalence and determinants of retinopathy in a cohort of Lebanese type II diabetic patients. Can J Ophthalmol 2009;44:308-313.
53. Chen MS, Kao CS, Fu CC, Chen CJ, Tai TY. Incidence and progression of diabetic retinopathy among non-insulindependent diabetic subjects: A 4-year follow-up. Int J Epidemiol 1995;24:787-795.
54. Tapp RJ, Shaw JE, Harper CA, de Courten MP, Balkau B, McCarty DJ, et al. The prevalence of and factors associated with diabetic retinopathy in the Australian population. Diabetes Care 2003;26:1731-1737.
55. Wong TY, Klein R, Islam FM, Cotch MF, Folsom AR, Klein BE, et al. Diabetic retinopathy in a multi-ethnic cohort in the United States. Am J Ophthalmol 2006;141: 446-455.
56. Haffner SM, Fong D, Stern MP, Pugh JA, Hazuda HP, Patterson JK, et al. Diabetic retinopathy in Mexican Americans and non-Hispanic whites. Diabetes 1988;37: 878-884.
57. Hamman RF, Mayer EJ, Moo-Young GA, Hildebrandt W, Marshall JA, Baxter J. Prevalence and risk factors of diabetic retinopathy in non-Hispanic whites and Hispanics with NIDDM. San Luis Valley Diabetes Study. Diabetes 1989;38:1231-1237.
58. Kohner EM, Aldington SJ, Stratton IM, Manley SE, Holman RR, Matthews DR, et al. United Kingdom Prospective Diabetes Study, 30: Diabetic retinopathy at diagnosis of non-insulin-dependent diabetes mellitus and associated risk factors. Arch Ophthalmol 1998;116:297-303.
59. Stratton IM, Kohner EM, Aldington SJ, Turner RC, Holman RR, Manley SE, et al. UKPDS 50: Risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis. Diabetologia 2001; 44:156-163.
60. Nagi DK, Pettitt DJ, Bennett PH, Klein R, Knowler WC. Diabetic retinopathy assessed by fundus photography in Pima Indians with impaired glucose tolerance and NIDDM. Diabet Med 1997;14:449-456.
61. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol 1984;102: 527-532.
62. Klein R, Klein BE, Moss SE, Cruickshanks KJ. The Wisconsin Epidemiologic Study of diabetic retinopathy. XIV. Ten-year incidence and progression of diabetic retinopathy. Arch Ophthalmol 1994;112:1217-1228.
63. Kostev K, Rathmann W. Diabetic retinopathy at diagnosis of type 2 diabetes in the UK: A database analysis. Diabetologia 2012;56:109-111.
64. Looker HC, Nyangoma SO, Cromie D, Olson JA, Leese GP, Black M, et al. Diabetic retinopathy at diagnosis of type 2 diabetes in Scotland. Diabetologia 2012;55:2335-2342.
65. Varma R, Macias GL, Torres M, Klein R, Pea FY, Azen SP, et al. Biologic risk factors associated with diabetic retinopathy: The Los Angeles Latino Eye Study. Ophthalmology 2007;114:1332-1340.
66. West SK, Munoz B, Klein R, Broman AT, Sanchez R, Rodriguez J, et al. Risk factors for Type II diabetes and diabetic retinopathy in a Mexican-American population: Proyecto VER. Am J Ophthalmol 2002;134:390-398.
67. Zhang X, Saaddine JB, Chou CF, Cotch MF, Cheng YJ, Geiss LS, et al. Prevalence of diabetic retinopathy in the United States, 2005-2008. JAMA 2010;304:649-656.
68. Pradeepa R, Anitha B, Mohan V, Ganesan A, Rema M. Risk factors for diabetic retinopathy in a South Indian Type 2 diabetic population-the Chennai Urban Rural Epidemiology Study (CURES) Eye Study. Diabet Med 2008;25:536-542.
69. Yoshida A, Kojima M, Ogasawara H, Ishiko S. Oscillatory potentials and permeability of the blood-retinal barrier in noninsulin-dependent diabetic patients without retinopathy. Ophthalmology 1991;98:1266-1271.
70. Bresnick GH, Palta M. Predicting progression to severe proliferative diabetic retinopathy. Arch Ophthalmol 1987; 105:810-814.
71. Birch DG, Anderson JL. Standardized full-field electroretinography. Normal values and their variation with age. Arch Ophthalmol 1992;110:1571-1576.
72. Vainio-Mattila B. The clinical electroretinogram; II. The difference between the electroretinogram in men and in women. Acta Ophthalmol (Copenh) 1951;29:25-32.
73. Zeidler I. The clinical electroretinogram. IX. The normal electroretinogram. Value of the b-potential in different age groups and its differenes in men and women. Acta Ophthalmol (Copenh) 1959;37:294-301.
74. Bearse MA, Adams AJ, Han Y, Schneck ME, Ng J, Bronson-Castain K, et al. A multifocal electroretinogram model predicting the development of diabetic retinopathy. Prog Retin Eye Res 2006;25:425-448.
75. Ozawa GY, Bearse Jr MA, Harrison WW, Bronson-Castain KW, Schneck ME, Barez S, et al. Differences in neuroretinal function between adult males and females. Optom Vis Sci 2014;91:602-607.
76. Weinstein M, Gorrindo T, Riley A, Mormino J, Niedfeldt J, Singer B, et al. Timing of menopause and patterns of menstrual bleeding. Am J Epidemiol 2003;158:782-791.
77. Huang X, Harlow SD, Elliott MR. Distinguishing 6 population subgroups by timing and characteristics of the menopausal transition. Am J Epidemiol 2012;175:74-83.
78. Fortune B, Schneck ME, Adams AJ. Multifocal electroretinogram delays reveal local retinal dysfunction in early diabetic retinopathy. Invest Ophthalmol Vis Sci 1999;40: 2638-2651.
79. Han Y, Schneck ME, Bearse MA, Barez S, Jacobsen CH, Jewell NP, et al. Formulation and evaluation of a predictive model to identify the sites of future diabetic retinopathy. Invest Ophthalmol Vis Sci 2004;45:4106-4112.
80. Ng JS, Bearse MA, Schneck ME, Barez S, Adams AJ. Local diabetic retinopathy prediction by multifocal ERG delays over 3 years. Invest Ophthalmol Vis Sci 2008;49: 1622-1628.
81. Harrison WW, Bearse MA, Ng JS, Jewell NP, Barez S, Burger D, et al. Multifocal electroretinograms predict onset of diabetic retinopathy in adult patients with diabetes. Invest Ophthalmol Vis Sci 2011;52:772-777.
82. Harrison WW, Bearse MA, Schneck ME, Wolff BE, Jewell NP, Barez S, et al. Prediction, by retinal location, of the onset of diabetic edema in patients with nonproliferative diabetic retinopathy. Invest Ophthalmol Vis Sci 2011; 52:6825-6831.
83. Ozawa GY, Bearse MA, Bronson-Castain KW, Harrison WW, Schneck ME, Barez S, et al. Neurodegenerative differences in the retinas of male and female patients with type 2 diabetes. Invest Ophthalmol Vis Sci 2012;53:3040-3046.
84. Steinberg HO, Paradisi G, Cronin J, Crowde K, Hempfling A, Hook G, et al. Type II diabetes abrogates sex differences in endothelial function in premenopausal women. Circulation 2000;101:2040-2046.
85. Kannel WB, McGee DL. Diabetes and cardiovascular disease. The Framingham study. JAMA 1979;241: 2035-2038.
86. Juutilainen A, Kortelainen S, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Gender difference in the impact of type 2 diabetes on coronary heart disease risk. Diabetes Care 2004;27:2898-2904.
87. Pan WH, Cedres LB, Liu K, Dyer A, Schoenberger JA, Shekelle RB, et al. Relationship of clinical diabetes and asymptomatic hyperglycemia to risk of coronary heart disease mortality in men and women. Am J Epidemiol 1986;123:504-516.
88. Jarrett RJ, McCartney P, Keen H. The Bedford survey: Ten year mortality rates in newly diagnosed diabetics, borderline diabetics and normoglycaemic controls and risk indices for coronary heart disease in borderline diabetics. Diabetologia 1982;22:79-84.
89. Kalyani RR, Lazo M, Ouyang P, Turkbey E, Chevalier K, Brancati F, et al. Gender differences in diabetes and risk of incident coronary artery disease in healthy young and middle-aged adults. Diabetes Care 2014;37:830-838.
90. Kazuya K, Hirashima T, Mori S, Natori T. Spontaneously diabetic rat ''OLETF'' as a model for NIDDM in humans. In: Shafrir E, editor. Lessons from animal diabetes. VI ed. Boston: Birkhauser; 1996:225-236.
91. Kawano K, Hirashima T, Mori S, Natori T. OLETF (Otsuka Long-Evans Tokushima Fatty) rat: A new NIDDM rat strain. Diabetes Res Clin Pract 1994;24: S317-S320.
92. Paik SG, Michelis MA, Kim YT, Shin S. Induction of insulin-dependent diabetes by streptozotocin. Inhibition by estrogens and potentiation by androgens. Diabetes 1982; 31:724-729.
93. Boucher DW, Hayashi K, Rosenthal J, Notkins AL. Virus-induced diabetes mellitus: III. Influence of the sex and strain of the host. J Infect Dis 1975;131:462-466.
94. Franconi F, Seghieri G, Canu S, Straface E, Campesi I, Malorni W. Are the available experimental models of type 2 diabetes appropriate for a gender perspective? Pharmacol Res 2008;57:6-18.
95. Robinson R, Barathi VA, Chaurasia SS, Wong TY, Kern TS. Update on animal models of diabetic retinopathy: From molecular approaches to mice and higher mammals. Dis Model Mech 2012;5:444-456.
96. Liu S, Mauvais-Jarvis F. Minireview: Estrogenic protection of beta-cell failure in metabolic diseases. Endocrinology 2010;151:859-864.
97. Costrini NV, Kalkhoff RK. Relative effects of pregnancy, estradiol, and progesterone on plasma insulin and pancreatic islet insulin secretion. J Clin Invest 1971;50: 992-999.
98. Jiang M, He J, Kucera H, Gaikwad N, Zhang B, Xu MW, et al. Hepatic over-expression of steroid sulfatase ameliorates mouse models of obesity and type 2 diabetes through sex-specific mechanisms. J Biol Chem 2014;289: 8086-8097.
99. Manson JE, Chlebowski RT, Stefanick ML, Aragaki AK, Rossouw JE, Prentice RL, et al. Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials. JAMA 2013;310: 1353-1368.
100. Kanaya AM, Herrington D, Vittinghoff E, Lin F, Grady D, Bittner V, et al. Glycemic effects of postmenopausal hormone therapy: The Heart and Estrogen/progestin Replacement Study. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 2003;138:1-9.
101. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047-1053.
102. Appiah D, Winters SJ, Hornung CA. Bilateral oophorectomy and the risk of incident diabetes in postmenopausal women. Diabetes Care 2014;37:725-733.
103. Yuen KK, Kahn HA. The association of femal hormones with blindness from diabetic retinopathy. Am J Ophthalmol 1976;81:820-822.
104. Icks A, Trautner C, Haastert B, Berger M, Giani G. Blindness due to diabetes: Population-based age-and sex-specific incidence rates. Diabet Med 1997;14:571-575.
105. Ghafour IM, Allan D, Foulds WS. Common causes of blindness and visual handicap in the west of Scotland. Br J Ophthalmol 1983;67:209-213.
106. Gunderson EP, Lewis CE, Tsai AL, Chiang V, Carnethon M, Quesenberry CP, et al. A 20-year prospective study of childbearing and incidence of diabetes in young women, controlling for glycemia before conception: The Coronary Artery Risk Development in Young Adults (CARDIA) Study. Diabetes 2007;56:2990-2996.
107. Skouby SO. Hormonal contraception in obesity, the metabolic syndrome, and diabetes. Ann NY Acad Sci 2010;1205:240-244.
108. Kharazmi E, Lukanova A, Teucher B, Gross ML, Kaaks R. Does pregnancy or pregnancy loss increase later maternal risk of diabetes? Eur J Epidemiol 2012;27:357-366.
109. Nicholson WK, Fox HE, Cooper LA, Strobino D, Witter F, Powe NR. Maternal race, procedures, and infant birth weight in type 2 and gestational diabetes. Obstet Gynecol 2006;108:626-634.
110. Axer-Siegel R, Fink-Cohen S, Hod M, Weinberger D, Loya N, Yassur Y. Evaluation of diabetic retinopathy during pregnancy by green monochromatic fundus photography. J Diabetes Complications 1997;11:172-175.
111. Phelps RL, Sakol P, Metzger BE, Jampol LM, Freinkel N. Changes in diabetic retinopathy during pregnancy. Correlations with regulation of hyperglycemia. Arch Ophthalmol 1986;104:1806-1810.
112. Moloney JB, Drury MI. The effect of pregnancy on the natural course of diabetic retinopathy. Am J Ophthalmol 1982;93:745-756.
113. The Diabetes Control and Complications Trial Research Group. Effect of pregnancy on microvascular complications in the diabetes control and complications trial: The Diabetes Control and Complications Trial Research Group. Diabetes Care 2000;23:1084-1091.
114. Horvat M, Maclean H, Goldberg L, Crock GW. Diabetic retinopathy in pregnancy: A 12-year prospective survey. Br J Ophthalmol 1980;64:398-403.
115. Lovestam-Adrian M, Agardh CD, Aberg A, Agardh E. Pre-eclampsia is a potent risk factor for deterioration of retinopathy during pregnancy in Type 1 diabetic patients. Diabet Med 1997;14:1059-1065.
116. Lapolla A, Cardone C, Negrin P, Midena E, Marini S, Gardellin C, et al. Pregnancy does not induce or worsen retinal and peripheral nerve dysfunction in insulindependent diabetic women. J Diabetes Comp 1998;12: 74-80.
117. Errera MH, Kohly RP, da Cruz L. Pregnancy-associated retinal diseases and their management. Surv Ophthalmol 2013;58:127-142.
118. Sheth BP. Does pregnancy accelerate the rate of progression of diabetic retinopathy? An update. Curr Diab Rep 2008;8:270-273.
119. Sondheimer S. Metabolic effects of the birth control pill. Clin Obstet Gynecol 1981;24:927-941.
120. Porkka KV, Erkkola R, Taimela S, Raitakari OT, Dahlen GH, Viikari JS. Influence of oral contraceptive use on lipoprotein (a) and other coronary heart disease risk factors. Ann Med 1995;27:193-198.
121. Sheu WH, Hsu CH, Chen YS, Jeng CY, Fuh MM. Prospective evaluation of insulin resistance and lipid metabolism in women receiving oral contraceptives. Clin Endocrinol (Oxf) 1994;40:249-255.
122. Straznicky NE, Barrington VE, Branley P, Louis WJ. A study of the interactive effects of oral contraceptive use and dietary fat intake on blood pressure, cardiovascular reactivity and glucose tolerance in normotensive women. J Hypertens 1998;16:357-368.
123. Deleskog A, Hilding A, Ostenson CG. Oral contraceptive use and abnormal glucose regulation in Swedish middle aged women. Diabetes Res Clin Pract 2011;92:288-292.
124. Rosenthal AD, Shu XO, Jin F, Yang G, Elasy TA, Li Q, et al. Oral contraceptive use and risk of diabetes among Chinese women. Contraception 2004;69:251-257.
125. Visser J, Snel M, Van Vliet HA. Hormonal versus non-hormonal contraceptives in women with diabetes mellitus type 1 and 2. Cochrane Database Syst Rev 2013;3: CD003990.
126. Widom B, Diamond MP, Simonson DC. Alterations in glucose metabolism during menstrual cycle in women with IDDM. Diabetes Care 1992;15:213-220.
127. Goldner WS, Kraus VL, Sivitz WI, Hunter SK, Dillon JS. Cyclic changes in glycemia assessed by continuous glucose monitoring system during multiple complete menstrual cycles in women with type 1 diabetes. Diabetes Technol Ther 2004;6:473-480.
128. Barata DS, Adan LF, Netto EM, Ramalho AC. The effect of the menstrual cycle on glucose control in women with type 1 diabetes evaluated using a continuous glucose monitoring system. Diabetes Care 2013;36:e70.